Early antibody response to SARS-CoV-2
Dittadi, R.; Afshar, H.; Carraro, P.
Show abstract
BackgroundThe role and significance of the immune response to SARS-CoV-2 infection is not yet well known. MethodsWe conducted a study on 46 symptomatic subjects with disease confirmed by laboratory tests, to evaluate the presence of IgG and IgM antibodies in these subjects in relation to the time elapsed since the onset of symptoms. The analytical performance of the method used in the study and the effect of two different serum and plasma matrices were also assessed. ResultsIgG positivity was demonstrated in 100% of cases 15 days after the onset of the disease. IgM show lower concentrations and do not exceed 77% of cases after 15 days. The analytical performance of the method used (Maglumi 800, Snibe, China) was confirmed to be good in terms of imprecision, linearity and commutability in two sample matrix. ConclusionThe serological study through the search for specific IgG for SARS-CoV-2 results to be sensitive and suitable for population research and evidences that this approach can also play an important role in diagnosis. The diagnostic performance of specific IgMs are lower.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A High-throughput Microsphere-based Immunoassay of Anti-SARS-CoV-2 IgM Testing for COVID-19 Diagnostics 96%
- Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan 96%
- Development And Performance Evaluation of A Rapid In-House ELISA for Retrospective Serosurveillance of SARS-CoV-2 95%
Similar papers in this journal
- Diagnostic comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies 96%
- Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2 94%
- Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis 93%
Similar papers in this journal
- A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots 95%
- Hilab system, a new point-of-care hematology analyzer supported by the Internet of Things and Artificial Intelligence 94%
- Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis 94%
Similar papers in this journal
- Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals 94%
- Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals 94%
- Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2 93%
Similar papers in this journal
- Evaluation the auxiliary diagnosis value of antibodies assays for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19) 94%
- Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam 93%
- Evaluation of seven different rapid methods for nucleic acid detection of SARS-COV-2 virus 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.